Literature DB >> 9619382

A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology.

M J Buckley1, J O'Shea, A Grace, L English, C Keane, D Hourihan, C A O'Morain.   

Abstract

OBJECTIVES: To document the epidemiology of Helicobacter pylori infection in a normal population, to assess asymptomatic H. pylori positive individuals for the presence of gastroduodenal disease, and to compare the macroscopic and microscopic findings at endoscopy in this group with those of patients presenting with dyspepsia. DESIGN/
METHODS: Serum was collected from blood donors and assessed for the presence of anti-H. pylori IgG antibodies. A randomly selected group of asymptomatic blood donors and dyspeptic patients underwent endoscopy.
RESULTS: The seroprevalence of H. pylori in 1000 subjects was 43.0%. The prevalence of infection increased from 29% in 18-30 year olds to 62% in 46-60 year olds (P < 0.01). The infection was more prevalent in individuals from social classes IV and V (50.0%) than social classes I and II (36.9%) (P < 0.01). There was no difference between the H. pylori positive asymptomatic individuals (n = 37) and matched dyspeptic patients (n = 29) at endoscopy with regard to duodenal ulcer (13.5% vs. 17.2%) or gastroduodenal erosions (24.3% vs. 20.7%) while 5.4% of the former had gastro-oesophageal reflux compared to 27.6% of the latter. Overall, 56.8% of the H. pylori positive asymptomatic group had a normal macroscopic endoscopy compared with 31% of the dyspeptic group. Histology of the gastric mucosa did not reveal any significant differences between the two groups. In H.pylori negative asymptomatic individuals (n = 13) 92.3% had a normal endoscopy (7.7% had grade I gastro-oesophageal reflux) compared with 61.5% of a matched dyspeptic group (n = 13).
CONCLUSION: H.pylori infection, symptomatic and asymptomatic, is associated with significant pathology, and screening for the infection may be indicated for the prevention of gastroduodenal diseases.

Entities:  

Mesh:

Year:  1998        PMID: 9619382     DOI: 10.1097/00042737-199805000-00004

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  15 in total

Review 1.  The occupational risk of Helicobacter pylori infection: a systematic review.

Authors:  Hassan Kheyre; Samantha Morais; Ana Ferro; Ana Rute Costa; Pedro Norton; Nuno Lunet; Bárbara Peleteiro
Journal:  Int Arch Occup Environ Health       Date:  2018-05-29       Impact factor: 3.015

2.  Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults.

Authors:  P Bytzer; S Howell; M Leemon; L J Young; M P Jones; N J Talley
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

3.  Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China.

Authors:  Hao Li; Xue-Liang Chen; Hui-Qing Li
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

4.  HpSA: assessment of a new non-invasive diagnostic assay for Helicobacter pylori infection in an Irish population.

Authors:  D McNamara; H Whelan; H Hamilton; S Beattie; C O'Morain
Journal:  Ir J Med Sci       Date:  1999 Apr-Jun       Impact factor: 1.568

5.  Patterns of gastritis in patients with gastro-oesophageal reflux disease.

Authors:  D J Bowrey; G W Clark; G T Williams
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

6.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 7.  Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.

Authors:  Geoffrey W B Clark
Journal:  World J Surg       Date:  2003-07-24       Impact factor: 3.352

8.  Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects.

Authors:  D Vaira; N Vakil; M Rugge; L Gatta; C Ricci; M Menegatti; G Leandro; J Holton; V M Russo; M Miglioli
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

Review 9.  Epidemiology of gastric cancer.

Authors:  Katherine D Crew; Alfred I Neugut
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

Review 10.  The stomach in health and disease.

Authors:  R H Hunt; M Camilleri; S E Crowe; E M El-Omar; J G Fox; E J Kuipers; P Malfertheiner; K E L McColl; D M Pritchard; M Rugge; A Sonnenberg; K Sugano; J Tack
Journal:  Gut       Date:  2015-09-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.